Cytogenetic analysis was performed on 40 non-Hodgkin's lymphoma (NHQ node biopsies. Chromosomes X, 3 and 12 were the most frequently gained; of the much rarer monosomies, loss of chromosome 13 was most common. Structural abnormalities primarily involved chromosomes 14,1,18,6 and 17. A markedly greater number of chromosome gains were associated with low-grade disease when compared to high-grade. In order to obtain further information from the cytogenetic analysis of the NHL karyotypes, the fluorescence in-situ hybridisation (FISH) technique was applied to the series. The activation state of additional X-chromosomes was examined and evidence that more than one X-chromosome was present in the active state in 4/9 cases was obtain...
Chronic mature B-cell lymphoproliferative disorders, i.e. B-cell chronic lymphocytic leukemia (CLL) ...
BACKGROUND: The technique of Fluorescence In-Situ Hybridization (FISH), a hybrid of cytogenetics and...
Malignant lymphoproliferative disorders include highly heterogeneous entities, i.e. lymphomas (Non-H...
Cytogenetic analysis was performed on 40 non-Hodgkin's lymphoma (NHQ node biopsies. Chromosomes X...
The detection of specific chromosomal abnormalities is important in the diagnostic workup of aggress...
Cytogenetic analysis of the malignant clone is clinically important in haematological malignancy. A...
Lymphomas are a group of heterogeneous malignant neoplasms involving B, T and NK lymphocytes. Their ...
A patient with acute nonlymphocytic leukemia (ANLL), M5b according to French-American-British (FAB) ...
To determine whether recurrent genomic imbalances are a feature of HL, CD30-positive HRS cells were ...
Lymphomas originating from the lymphatic system comprise about 30 entities classified according to t...
Cytogenetic analysis using Giemsa banding technique was successful in 30 of the 49 adult patients wi...
Background. In chronic lymphocytic leukemia (CLL) molecular cytogenetic abnormalities may identify s...
This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.o...
The use of fluorescence in situ hybridization (FISH) for the purpose of repeated follow-up examinat...
BACKGROUND: The technique of Fluorescence In-Situ Hybridization (FISH), a hybrid of cytogenetics and...
Chronic mature B-cell lymphoproliferative disorders, i.e. B-cell chronic lymphocytic leukemia (CLL) ...
BACKGROUND: The technique of Fluorescence In-Situ Hybridization (FISH), a hybrid of cytogenetics and...
Malignant lymphoproliferative disorders include highly heterogeneous entities, i.e. lymphomas (Non-H...
Cytogenetic analysis was performed on 40 non-Hodgkin's lymphoma (NHQ node biopsies. Chromosomes X...
The detection of specific chromosomal abnormalities is important in the diagnostic workup of aggress...
Cytogenetic analysis of the malignant clone is clinically important in haematological malignancy. A...
Lymphomas are a group of heterogeneous malignant neoplasms involving B, T and NK lymphocytes. Their ...
A patient with acute nonlymphocytic leukemia (ANLL), M5b according to French-American-British (FAB) ...
To determine whether recurrent genomic imbalances are a feature of HL, CD30-positive HRS cells were ...
Lymphomas originating from the lymphatic system comprise about 30 entities classified according to t...
Cytogenetic analysis using Giemsa banding technique was successful in 30 of the 49 adult patients wi...
Background. In chronic lymphocytic leukemia (CLL) molecular cytogenetic abnormalities may identify s...
This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.o...
The use of fluorescence in situ hybridization (FISH) for the purpose of repeated follow-up examinat...
BACKGROUND: The technique of Fluorescence In-Situ Hybridization (FISH), a hybrid of cytogenetics and...
Chronic mature B-cell lymphoproliferative disorders, i.e. B-cell chronic lymphocytic leukemia (CLL) ...
BACKGROUND: The technique of Fluorescence In-Situ Hybridization (FISH), a hybrid of cytogenetics and...
Malignant lymphoproliferative disorders include highly heterogeneous entities, i.e. lymphomas (Non-H...